This list is an analysis based on recent market events. It's not an investment recommendation.
About
RecensMedical, Inc. operates as a medical device company specializing in precision cooling therapy and transdermal drug delivery solutions. The company engages in the development of precision medical cooling device in the fields of ophthalmology and dermatology. The company's products include OcuCool, a hand-held, cooling anesthesia device that provides rapid and controlled cooling to the conjunctiva and sclera, and TargetCool, a handheld device that delivers rapid, precise, and controlled cooling to the skin tissue for the temporary reduction of pain, swelling, inflammation, and hematoma from minor surgical procedures, minor sprains or other minor sports injuries. Additionally, it offers TargetCool+, a spray syringe; and VetEase, a spray syringe for animals. Its portfolio of clinical program includes ocular anesthesia, actinic keratosis, eczema, rosacea, prurigo nodularis, and atopic dermatitis. The company was founded in 2016 and is based in Hwaseong-si, South Korea.
The current price of 394420.KQ is ₩5,440 KRW — it has increased by +8.37% in the past 24 hours. Watch RecensMedical stock price performance more closely on the chart.
What is RecensMedical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange RecensMedical stocks are traded under the ticker 394420.KQ.
How many employees does RecensMedical have?▼
As of November 3, 2026, the company has 50 employees.
In which sector is RecensMedical located?▼
RecensMedical operates in the Other sector.
When did RecensMedical complete a stock split?▼
RecensMedical has not had any recent stock splits.
Where is RecensMedical headquartered?▼
RecensMedical is headquartered in Hwaseong-si, South Korea.